Update in treatments for macular degeneration and what to expect in 2025

Professor Richard Gale covers all the exciting developments for wet and dry AMD, as well as diabetic macular oedema. From recently approved treatments in the UK to the growing role of biosimilars, you can find out about the progress being made. Professor Gale will also reveal what’s in the pipeline, and why there’s reason to feel hopeful for the future as we move into 2025 and beyond.